Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
we need someone like boondocks saints of wall street. that would be pretty cool to watch play out.
Screw the short term shorts!
Why would there be a change to the milestone schedule? Punit, just a couple weeks ago, reiterated that he is still confident in delivering all of the milestones in 2014!
I agree furb. The PPS and company reminds me of a Jack Johnson song called, "sitting, waiting, wishing".
Any logical ideas on the reason why someone would want to hold the share price down, if indeed it is what's really happening.
With this low of volume, pretty much anyone could manipulate the price one way or the other. Just horrible to see that sometimes it's blatantly done.
Yea, just remember though that there are 2 other releases that could possibly happen this month. The new indication or the mcc data. This second grant was just another positive unexpected release. I suspect there are people waiting on the sidelines to get in, sooner rather than later I hope. Price really has support at these levels from all of the multiple catalysts that are expected to come out within the next few weeks!
Celtic, I think we blow past .55 today! That's less than 5 percent from where we are sitting at.
Twiz I get your frustration bc most of us are prob in the red still. I will give credit where credit is due to the posters who find this info and do great DD, thank you all! We as investors definately deserve a big run and finally make some real money on this stock. We have been here for a while, some longer then others. We believe in the company and the science and basically took time out of our lives to talk about and research the company. It will be a great Christmas for us all if we get the news we are hoping for. Everything looks on track and I think management is doing everything possible to raise the share price through meeting milestones and advancing the company!
Regardless, this is great news! It looks like they are finally getting some recognition and their science is getting validated by some organizations!
I get where ur coming from, but I'm just saying maybe it would have more of an impact on PPS if they released the two grants at the same time. Instead of release one with only 163k and this one with 500k. Who knows what they have planned with their information to release.
not ti be a debbie downer but do you guys think that we should be trying to dig up all this info not released yet and make it public before company does?i know that they didn't release the first grant given until someone mentioned it here. do you guys think they wanted to release both grants at the same time in one p.r? and the info about the conference with long term survival and phase 2a data. maybe they had something planned for that as well? just trying to look at it from companies perspective.
I'm thinking they had the phase two data before they submitted for the grants. Its a very positive indication of how good the data was!
Thanks lasers.
Gale released their phase 2a results today. They have 51 patients total in their 2a study, 29 in the vaccine group and 22 in the control group. Oncs uses IL-12 in with electroporation. So with our total patient population for our phase 2a in melanoma which I believe is 31 wouldnt we have a bigger variable group bc we don't need a control group (which would be the IL-12 itself)?
I really don't understand this theory of naked shorting. How can mm's short this much daily percentage and find enough shares to cover their positions without the share price skyrocketing? So if volume is 700k and they shirt 50 percent, isn't that 350k shares that they will eventually have to cover? And short percentage of that has been anywhere from 25-50 percent on the daily.
Well it might not run when we expect it to but I think the company is setting us up for a nice run heading into 2015. They have lined up all of their catalysts in a row by years end so that's when I'm expecting a run. Once the first major pop in PPS comes from an data release or pr then more and more people will discover oncs and jump on board. Just like a snowball rolling downhill collecting more snow and getting bigger. So many catalysts left in the year. I for one think that there will be a major run by years end. 100-200 percent up from these levels!
We will prob be sitting between .80-$1 after the phase 2a data is announced and before 2b.
Here's my very conservative PPS prediction from this level through December 31 given we meet all of our milestones. So we are at .5250, if they release new indication this month we can expect to see around a 10 percent overall gain in PPS which would put us at around .58 cents. By the time the December conference comes around and they release the phase 1 long term survival data we can be at -5 or +10 from that PPS so the range of between .53-.68 cents. So once phase 1 long term data is announced at conference we can expect to see a nice run up leading into final phase 2a melanoma data which would put us +10 to 20 percent up from that range. So average range would be .61-.78 cents. I'm expecting to see at least a 20 percent increase when phase 2a comes out so .73-.93.5 cents. We also have MCC data and phase 2b initiation. MCC if positive can see around a 10 percent increase conservatively so .80-1.03. Last is phase 2b if they announce with partner we can expect a really conservative increase of 40-60 percent so this range would now be averaged at 1.20-1.56. So there you have it, again I am being on the more conservative side and it's the morning so correct me if anything seems off.
because the shorts thought that after the news release about nov events that no other pr's would be released this week. i guess oncs showed them huh
They def had these P.R.'s planned for a while now. If this doesn't give investors the confidence that they will meet all of their stated milestones by years end idk what will. Notice how Pierce say "The POSITIVE findings from these monotherapy trials really set the stage for our next, critical study in melanoma – testing the combination of IL-12 gene transfer with an anti-PD1/PDL1 therapeutic." So there goes anyone theory about the data not being positive! They are setting us up really nicely for a potentially HUGE PPS move at the end of the year!
The company did not state that anything would get released at the conferences on september 26-29. Some investors presumed that we would be getting some new data release or something of consequence. I've been following the message boards closely and some investors are presuming and insinuating that we will get releases on certain days and events. When that doesn't come to fruition they disappoint not only themselves but also other message board members that take their word as truth when its only a guess. So the moral of the story would be not to try to predict when data and releases will come and do not get your hopes up to high when it doesn't come out when you expect. Just let things play out how they shall and then you can judge at the end of the year about how the company has handled things. good luck to all
if the final phase 2a data was sub par, i don't think that punt would state that phase 2b will begin by EOY
As we all know furbush is excellent when it comes to DD, but as he stated he is not very good at trading.
Do you think that they will release the data before the presentations and use the presentations to explain/ talk about the details of the data?
They have to deliver for credibility purposes as well as PPS purposes.
I didn't say they were going to release either one of these at a conference. They could just issue a pr at 6:03 am.
I think they already have a partnership for phase 2b. The reason they still present at partnership events are to get other partnerships for new indications. As punit has stated that he is still confident to complete milestones by year end which includes a initiation of phase 2b. He also stated in an Q&A that there is no way to do a phase 2b without a partner and the "anti Pd-1 drug isn't going to fall out of the sky"
Has dr. Pierce ever presented at an partnering conference at all or has it always been punit? I'm going to go out on a limb her and say we either get phase 2a final data tomorrow or a partnership announcement w Merck!
if he does come through and ops is over 1.50 by year end then i will spend the 1000 dollars to have a video conference call to thank him on behalf all of us.
lol punit is getting harassed on twitter on a daily basis. i kind of feel bad for him. same questions over and over again. its good that he is sticking to his guns with completiion of all the milestones by yea end. if one actually takes the time to reflect on the company, they will see how much the company actually accomplished in the last 1-2 years!
So did punit buy the 2 mil shares at .805 on 3/7/14 or did he exercise his options at a lower price to attain those shares? Trying to figure that out though the form 4 but a little confused on how to interpret it.
If that is true and he did buy and add 1.3 mil shares then that is a sign of good things to come and increases confidence in the future of the company. The shares might also be from bonuses and company incentive packages and such.
Where can i find out the percentage of short position at? Are they short sales or just people selling shares? 42% seems pretty high
yea its gets tiring seeing blatant low volume manipulation. i wish the company would just start the news releases already. it prob would have been better for them not to say anything at all about milestones being met by end of the year and just surprise us with the news.
Is it people selling or is it people shorting? I hope they release some surprise news tomorrow or this week to catch shorts trying to play games
yea that's what i was thinking. They are saving the phase 2a final data for when the partnership is negotiated and signed, then they will release consecutive milestones in a short period of time.
Fur, I think that's why no insiders in the company have been buying shares as of late. Maybe they are privaledged to insider information that won't allow them to purchase any shares at these prices. As to knowing more monday, how are you so certain we will get some more clarity then?
I'm thinking it is legal for them to show potential partners the phase 2a final melanoma trial data (which I think they already have) from what I've read on the link that IR sent me in the email. I think they are sitting on the data and will release it at the most opportune time before years end with other milestones to get the most increase in PPS as possible.
Emailed IR a question about if they have to make phase 2a melanoma final data public before showing it to potential partners.
Hello,
My name is Tinh Tupy and I have been pointed towards investor relations
by Punit via Twitter for my question. I was inquiring about the protocol
for the release of final phase 2a data. Is the company required to put
out a public release of the final phase 2a melanoma study data before
they show other potential partners the data for negotiation purposes for
phase 2b? I am just trying to get a personal pinpoint on where the
company is at in their milestones and partnership negotiations and this
information will help greatly. Thank you very much in advanced!
Sincerely, Tinh Tupy
Their reply,
Dear Tinh,
It seems your question might be referring to Regulation FD
(http://www.sec.gov/rules/final/33-7881.htm), the ³general rule regarding
selective disclosure.² We cannot provide legal advice or interpretation,
but we would suggest looking into Regulation FD and the related guidance
information released by the SEC. For example, these interpretations:
(http://www.sec.gov/divisions/corpfin/guidance/regfd-interp.htm)
Best Regards,
Corporate Communications Team
855.662.6732 | investors@oncosec.com